Cargando…
Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma
BACKGROUND: The SRY-related HMG-box family of transcription factors member SOX2 has been mainly studied in embryonic stem cells as well as early foregut and neural development. More recently, SOX2 was shown to participate in reprogramming of adult somatic cells to a pluripotent stem cell state and i...
Autores principales: | Lengerke, Claudia, Fehm, Tanja, Kurth, Ralf, Neubauer, Hans, Scheble, Veit, Müller, Friederike, Schneider, Friederike, Petersen, Karen, Wallwiener, Diethelm, Kanz, Lothar, Fend, Falko, Perner, Sven, Bareiss, Petra M, Staebler, Annette |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038979/ https://www.ncbi.nlm.nih.gov/pubmed/21276239 http://dx.doi.org/10.1186/1471-2407-11-42 |
Ejemplares similares
-
Molecular and functional interactions between AKT and SOX2 in breast carcinoma
por: Schaefer, Thorsten, et al.
Publicado: (2015) -
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients
por: Fehm, Tanja, et al.
Publicado: (2008) -
Incidence and Impact of Lymph Node Metastases in Advanced Ovarian Cancer: Implications for Surgical Treatment
por: Bachmann, Cornelia, et al.
Publicado: (2016) -
Antitumor activity of zoledronic acid in primary breast cancer cells determined by the ATP tumor chemosensitivity assay
por: Fehm, Tanja, et al.
Publicado: (2012) -
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2012)